News Headlines Article

HIV, spinal cord treatments win $20 million in stem cell agency awards
San Francisco Business Times

Experimental HIV and spinal cord injury treatments under commercial development by two Bay Area companies won a combined $20 million in funding from California’s stem cell research funding agency Thursday. Sangamo BioSciences Inc. (NASDAQ: SGMO) of Richmond will split a $5.6 million California Institute for Regenerative Medicine award with Dr. John Zaia of the Beckman Research Institute at the City of Hope near Los Angeles to take blood stem cells from HIV patients and cut and replace a gene that is key to the spread of the AIDS virus.